IBSA at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Paris, April 2019
IBSA will be present at the 18th edition of the WCO-IOF-ESCEO Congress which will take place in Paris, France, April 4th to 7th, 2019
IBSA gladly announces the participation at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO), Paris, April 4th-7th 2019 https://www.wco-iof-esceo.org/. IBSA is attending the congress with a Satellite Symposium on the main product of the company in the field of OA treatment, our pharmaceutical-grade chondroitin sulfate (Friday, April 5th 2019, 17.00 - 18.30, Auditorium B): “Differences in the efficacy of various Chondroitin Sulfate preparations: Facts or fantasy?”. Please find here the full programme.